MissionIRNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Advances Novel Multiple Sclerosis Therapy Toward Phase 2 Trials

MiningNewsBreaks – Nevada Organic Phosphate Inc. (CSE: NOP) (OTCQB: NOPFF) Publishes Updated Investor Materials Highlighting New Drill...

BioMedNewsBreaks — NanoViricides (NYSE American: NNVC) Ships NV-387 Drug Supply to DRC for Phase II MPox Trial

MissionIRNewsBreaks – Greenland Mines Ltd (NASDAQ: GRML) Signs Drilling Contract for 2026 Skaergaard Field Program

TechMediaBreaks – SPARC AI Inc. (CSE: SPAI) (OTCQB: SPAIF) (Frankfurt: 5OV0) Gains AUKUS Authorization for Permit-Free Defense Technology...

NetworkNewsBreaks – Silvercorp Metals Inc. (TSX: SVM) (NYSE American: SVM) Approves $196.3 Million Budget for Kyrgyz Gold Project...

BioMedNewsBreaks — Onco-Innovations Limited (CBOE CA: ONCO) (OTCQB: ONNVF) (Frankfurt: W1H) (WKN: A3EKSZ) Targets Next Wave of DNA Damage...

InvestorNewsBreaks – Nocera, Inc. (NASDAQ: NCRA) Highlights CampaignPulse.ai Investment and Expands AI Platform Vision

As MiCA License Deadline Looms, Most EU Crypto Firms Haven’t Complied

Global Investment in Clean Energy Reaches Record Level

Novel Patented Myelin Drug-Discovery Strategy Targets Massive Unmet Need in Multiple Sclerosis

Next-Generation DNA Repair Therapies Open New Frontiers in Oncology

Study Finds That AI is Eroding Ecommerce Shoppers’ Trust

The Fed Keeps Current Lending Rate, Signals Possible Hike Later

NetworkNewsBreaks – Nightfood Holdings Inc. (OTCQB: NGTF) Featured in Audio Editorial on AI Infrastructure Automation Opportunity

CurrencyNewsBreaks – What Are I Bonds and Why Are They Paying 4.26%?

CurrencyNewsBreaks – Foreign Investors Added $206 Billion to U.S. Securities in April, Treasury Reports

TechMediaBreaks – Xeriant, Inc. (OTCQB: XERI) Advances NEXBOARD Commercialization with Production Run for Builder Evaluations

DefenseNewsBreaks – M-tron Industries, Inc. (NYSE American: MPTI) Secures $6.8 Million Follow-On Defense Order for C-UAS Radar Programs

InvestorNewsBreaks – Knight Therapeutics Inc. (TSX: GUD) Repays Credit Facility Used to Fund Paladin Acquisition